This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Antitrust - US FTC - Express Scripts' litigation over interim report on PBMs (US)

Express Scripts filed a complaint against the US Federal Trade Commission over the agency’s interim report on pharmacy benefit managers, saying it's full of unsupported innuendo leveled against it and other PBMs “under a false and defamatory headline and accompanied by a false and defamatory press release.” The company argued that the report followed prejudice and politics, not evidence or sound economics, and wrongly concluded that PBMs inflate drug costs and harm independent pharmacies. Express asks that the report be vacated and corrected and that FTC Chair Lina Khan be recused from further proceedings regarding Express Scripts in light of her “evident bias.”

To add details to this portfolio regarding legal or economic representatives, please contact editors@mlex.com

Timeline

Parties

Get the inside track, with MLex

With a global network of expert journalists digging deep into the areas of risk that matter to your business and clients—and the highest standards of impartiality—you can have complete trust in MLex to keep you ahead of the regulatory curve.


  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from specialists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

TRY MLEX FREE FOR 14 DAYS

View the parties now

Already a subscriber? Click here to login